| 10/08 | PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales of $50.2 Million for July 2022 .. | PU |
| 10/08 | Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022 | GL |
| 09/08 | NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti.. | GL |
| 09/08 | NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communiti.. | GL |
| 03/08 | PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A.. | AQ |
| 03/08 | PACIRA BIOSCIENCES : Reports Second Quarter 2022 Financial Results - Form 8-K | PU |
| 03/08 | PACIRA : Q2 Earnings Snapshot | AQ |
| 03/08 | Pacira BioSciences Reports Second Quarter 2022 Financial Results | GL |
| 03/08 | Pacira BioSciences Reports Second Quarter 2022 Financial Results | AQ |
| 02/08 | Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca.. | GL |
| 02/08 | Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthca.. | AQ |
| 27/07 | Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022 | GL |
| 27/07 | Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022 | GL |
| 14/07 | PACIRA BIOSCIENCES : Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million - F.. | PU |
| 14/07 | Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million | GL |
| 16/06 | National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog.. | GL |
| 16/06 | National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Prog.. | PR |
| 14/06 | PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46... | PU |
| 14/06 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.. | GL |
| 14/06 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.. | AQ |
| 10/06 | PACIRA BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission of Matter.. | AQ |
| 02/06 | Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conferen.. | GL |
| 25/05 | Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD REC.. | PR |
| 12/05 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.. | GL |
| 10/05 | Pacira BioSciences to Present at Two Healthcare Conferences in May | GL |
| 10/05 | Pacira BioSciences to Present at Two Healthcare Conferences in May | AQ |
| 04/05 | PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A.. | AQ |
| 04/05 | PACIRA : Q1 Earnings Snapshot | AQ |
| 04/05 | PACIRA BIOSCIENCES, INC. : Results of Operations and Financial Condition, Change in Direct.. | AQ |
| 04/05 | Pacira BioSciences Reports First Quarter 2022 Financial Results | GL |
| 04/05 | Pacira BioSciences Reports First Quarter 2022 Financial Results | AQ |
| 27/04 | Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022 | GL |
| 12/04 | PACIRA BIOSCIENCES : Reports Preliminary Revenues of $157.4 to $158.4 Million for the Firs.. | PU |
| 12/04 | Pacira BioSciences Reports Preliminary Revenues of $157.4 to $158.4 Million for the Fir.. | AQ |
| 05/04 | Pacira BioSciences to Participate in Fireside Chat at the 21st Annual Needham Virtual H.. | AQ |
| 15/03 | PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42... | PU |
| 15/03 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $4.. | AQ |
| 09/03 | Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Co.. | AQ |
| 28/02 | PACIRA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition a.. | AQ |
| 24/02 | PACIRA : Q4 Earnings Snapshot | AQ |
| 24/02 | PACIRA BIOSCIENCES : Reports Full-Year and Fourth Quarter 2021 Financial Results - Form 8-.. | PU |
| 24/02 | Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results | AQ |
| 16/02 | Pacira to Report 2021 Financial Results on Thursday February 24, 2022 | AQ |
| 15/02 | PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37... | PU |
| 15/02 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.. | GL |
| 07/02 | PACIRA BIOSCIENCES, INC. Financial Statements and Exhibits (form 8-K/A) | AQ |
| 07/02 | PACIRA BIOSCIENCES : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS - Form 8-.. | PU |
| 06/01 | PACIRA BIOSCIENCES : Reports Preliminary Unaudited Total Revenue for 2021 of of $540.7 Mil.. | PU |
| 06/01 | Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7.. | AQ |
| 03/01 | Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference | AQ |
| 2021 | PACIRA BIOSCIENCES : Announces Closing of $375 Million Five-Year Term Loan B - Form 8-K | PU |
| 2021 | PACIRA BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Creation of a Direc.. | AQ |
| 2021 | Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B | GL |
| 2021 | PACIRA BIOSCIENCES : Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.. | PU |
| 2021 | Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $4.. | AQ |
| 2021 | Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Confe.. | GL |
| 2021 | PACIRA BIOSCIENCES : Completes Acquisition of Flexion Therapeutics and Strengthens Leaders.. | PU |
| 2021 | PACIRA BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Completion of Acqui.. | AQ |
| 2021 | Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leader.. | GL |
| 2021 | Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leader.. | GL |
| 2021 | Pacira BioSciences to Present at the Jefferies London Healthcare Conference | GL |
| 2021 | Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2.. | PU |
| 2021 | Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2.. | GL |
| 2021 | Pacira Files Lawsuit Against eVenus for Patent Infringement | AQ |
| 2021 | PACIRA BIOSCIENCES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A.. | AQ |
| 2021 | Pacira BioSciences Reports Third Quarter 2021 Financial Results - Form 8-K | PU |
| 2021 | PACIRA : Q3 Earnings Snapshot | AQ |
| 2021 | Pacira BioSciences Reports Third Quarter 2021 Financial Results | AQ |
| 2021 | Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition | GL |
| 2021 | Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021 | GL |
| 2021 | PACIRA BIOSCIENCES : to Acquire Flexion Therapeutics Further Expanding Leadership Position.. | PU |
| 2021 | PACIRA BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Results of Operatio.. | AQ |
| 2021 | PACIRA BIOSCIENCES : to Acquire Flexion Therapeutics Further Expanding Leadership Position.. | GL |
| 2021 | PACIRA BIOSCIENCES : to Host Investor Day on October 15th, 2021 in Tampa, FL | GL |
| 2021 | Nu Skin, Pacira Biosciences fall; Veoneer, Tesla rise | AQ |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
